How Profit Pressures Can Crush Everything Good About Efforts to Improve Healthcare


A key District court decision against United Behavioral Health (UBH), a subsidiary of the country’s largest insurer United Healthcare and the country’s largest behavioral health provider, noted that UBH created internal policies that illegally denied treatment to thousands of patients, and put profits over patients. The case will now move into the remedy phase where penalties will be determined. United Health Group is expected to appeal.

If we continue to put profit over health, the U.S. health system will continue its slide towards becoming a second rate health system that delivers quality care only to those with the highest income. The only way out is through the consumer.  Washington is too embroiled in a political tug of war, insurance and health providers only see financial pressures growing due to rising costs and an ageing population, and medical records providers try to hold on to their market share by blocking the data sharing that is critical to achieving quality outcomes.

Blood Pressure Drug Recall


The recent recall of drug pressure medication Losartin (25mg, 50mg, and 100 mgs) is part of a larger investigation by the U.S. Food and Drug Administration (FDA) into multiple generic high blood pressure medications. Losartin is part of a class of drugs called angiotensin II receptor blockers (ARB).

The FDA has been working with multiple drug manufacturers to identify and correct multiple impurities in this class of drugs. The complete list of Losartin products in this recent recall is available from the FDA.

The current recommendation for patients taking and ARB drug is to contact their pharmacist or physician to discuss whether a replacement is necessary. Not all ARB drugs contain impurities.